Method and system for tailored anti-cancer therapy based on the information of genomic sequence variant and survival of cancer patient

摘要

The present invention relates to a method and a system for selecting a customized drug by using information on cancer genome base sequence mutation and on patient survival. More specifically, the present invention relates to a method and a system for selecting a customized anticancer treating drug by using information on mutation of a synthetic cancer survival gene from cancer genome base sequence mutations. The method and the system of the present invention use cancer genome mutation and patient survival information, or use cancer cell or tissue infiltration or metastasis ability evaluation. By analyzing mutation of a synthetic cancer survival gene pair induced from cancer genome base sequence mutation and cancer survival and metastasis information, an anticancer treating drug having a good treating effect and a good prognosis can be effectively selected for individuals. High reliability is ensured, and related information can be rapidly and simply provided.